Skip to content
10-Q

Quarterly Report

SYNAGEVA BIOPHARMA CORP

0001193125-14-288130

← back to feed
Filed
Jul 31, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Jul 25, 2014 33.17M sh
Shares Diluted Q2 2014 · Jun 30, 2014 33.06M sh
Shares Diluted Q2 2014 · Jun 30, 2014 32.21M sh
Shares Diluted Q2 2014 · Jun 30, 2013 27.28M sh
Shares Diluted Q2 2014 · Jun 30, 2013 27.06M sh
Capex Q2 2014 · Jun 30, 2014 $8.88M
Capex Q2 2014 · Jun 30, 2013 $7.94M
Short Term Investments Q2 2014 · Jun 30, 2014 $464.05M
Short Term Investments Q2 2014 · Dec 31, 2013 $346.6M
Cash And Equivalents Q2 2014 · Jun 30, 2014 $70.45M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $62.14M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $47.76M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $23.88M
Stockholders Equity Q2 2014 · Jun 30, 2014 $560.61M
Stockholders Equity Q2 2014 · Dec 31, 2013 $430.2M
Current Liabilities Q2 2014 · Jun 30, 2014 $27.27M
Current Liabilities Q2 2014 · Dec 31, 2013 $13.92M
Total Liabilities Q2 2014 · Jun 30, 2014 $32.62M
Total Liabilities Q2 2014 · Dec 31, 2013 $17.75M
Current Assets Q2 2014 · Jun 30, 2014 $545.64M
Current Assets Q2 2014 · Dec 31, 2013 $416.72M
Total Assets Q2 2014 · Jun 30, 2014 $593.24M
Total Assets Q2 2014 · Dec 31, 2013 $447.95M
Eps Diluted Q2 2014 · Jun 30, 2014 −$1.52
Eps Diluted Q2 2014 · Jun 30, 2014 −$2.69
Eps Diluted Q2 2014 · Jun 30, 2013 −$0.81
Eps Diluted Q2 2014 · Jun 30, 2013 −$1.35
Eps Basic Q2 2014 · Jun 30, 2014 −$1.52
Eps Basic Q2 2014 · Jun 30, 2014 −$2.69
Eps Basic Q2 2014 · Jun 30, 2013 −$0.81
Eps Basic Q2 2014 · Jun 30, 2013 −$1.35
Sga Expense Q2 2014 · Jun 30, 2014 $12.59M
Sga Expense Q2 2014 · Jun 30, 2014 $22.4M
Sga Expense Q2 2014 · Jun 30, 2013 $6.44M
Sga Expense Q2 2014 · Jun 30, 2013 $12.1M
Rd Expense Q2 2014 · Jun 30, 2014 $39.53M
Rd Expense Q2 2014 · Jun 30, 2014 $67.4M
Rd Expense Q2 2014 · Jun 30, 2013 $18.45M
Rd Expense Q2 2014 · Jun 30, 2013 $31.79M
Net Income Q2 2014 · Jun 30, 2014 −$50.24M
Net Income Q2 2014 · Jun 30, 2014 −$86.66M
Net Income Q2 2014 · Jun 30, 2013 −$22.11M
Net Income Q2 2014 · Jun 30, 2013 −$36.59M
Operating Income Q2 2014 · Jun 30, 2014 −$50.31M
Operating Income Q2 2014 · Jun 30, 2014 −$86.79M
Operating Income Q2 2014 · Jun 30, 2013 −$22.19M
Operating Income Q2 2014 · Jun 30, 2013 −$36.76M
Revenue Q2 2014 · Jun 30, 2014 $2.34M
Revenue Q2 2014 · Jun 30, 2014 $3.93M
Revenue Q2 2014 · Jun 30, 2013 $3.41M
Revenue Q2 2014 · Jun 30, 2013 $8.53M